医用大麻用于临终关怀的疼痛管理,作为计划阿片类药物的补充方法:单臂研究
Theodore Zanker1,2,3, Joseph Sacco1,2,4,5, James Prota2,6
1Department of Medicine, The Connecticut Hospice, Branford, CT, USA.
The American journal of hospice & palliative care
|December 15, 2023
概括
将医用大麻与阿片类药物结合起来,显著减少了宿舍患者的疼痛. 这种方法可能会降低阿片类药物的剂量和毒性,为终身疼痛管理提供更安全的替代方案.
科学领域:
- 息治疗和疼痛管理
- 综合性瘤学 综合性瘤学
- 药理学 药理学是指药理学的学科.
背景情况:
- 阿片类药物治疗对于临终关怀疼痛管理至关重要,但往往受到不良影响的限制.
- 医用大麻可能提供一种补充方法,以减轻阿片类药物的副作用,同时保持疼痛缓解.
研究的目的:
- 调查医用大麻和阿片类药物疗法的联合对宿舍住院患者疼痛缓解的影响.
- 评估阿片类药物剂量,食欲,呼吸功能,幸福感,恶心和不良事件的变化.
主要方法:
- 一项单臂研究涉及66名接受计划性阿片类药物治疗的成年宿舍住院患者.
- 参与者接受了标准化的口服医用大麻 (40毫克CBD/1.5毫克THC或80毫克CBD/3毫克THC).
- 纵向混合效应回归模型分析了996个治疗日的治疗效应.
主要成果:
- 观察到疼痛强度的统计学上显著的纵向减少 (P = .0029).
- 观察到一种非显著的趋势,即较低的阿片类药物剂量.
- 轻微,可逆的不良事件发生在4.5%的患者中;没有报告严重的不良事件.
结论:
- 结合医用大麻和阿片类药物治疗在宿舍患者中显示出显著的疼痛缓解.
- 这种组合可能会降低阿片类药物的剂量和毒性,呈现出潜在的更安全的疼痛管理选择.
- 对于终身护理机构,需要在更大规模的受控试验中进行进一步的调查.
相关概念视频
Continuing Care
1.5K
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.5K
Analgesia and Pain Management
628
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
628
Opioid Analgesics: Synthetic and Semisynthetic Opioids
302
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
302
Opioid Analgesics: Morphine and Other Natural Cogeners
253
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
253
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
282
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
282
Documentation in Long-Term and Home Healthcare Setting
893
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
893


